These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27068497)

  • 1. Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.
    Wang T; Zhang SF; Qiu MQ; Li QL
    Cancer Radiother; 2016 May; 20(3):181-6. PubMed ID: 27068497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
    Wan Y; Hui H; Wang X; Wu J; Sun S
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604).
    Tahara M; Fuse N; Mizusawa J; Sato A; Nihei K; Kanato K; Kato K; Yamazaki K; Muro K; Takaishi H; Boku N; Ohtsu A
    Cancer Sci; 2015 Oct; 106(10):1414-20. PubMed ID: 26250827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
    Wang HF; Lv JQ
    Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
    Wang WH; Bao Y; Chen M; Zhang L; Li KX; Xu GC; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2006 Oct; 25(10):1279-83. PubMed ID: 17059776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation maintenance therapy with S-1 in chemotherapy-naïve patients with advanced squamous cell lung cancer.
    Suzuki S; Karayama M; Inui N; Fujisawa T; Enomoto N; Nakamura Y; Kuroishi S; Matsuda H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Asada K; Masuda M; Yamada T; Watanabe H; Suda T
    Invest New Drugs; 2016 Aug; 34(4):490-6. PubMed ID: 27279143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0801.
    Aoe K; Takigawa N; Hotta K; Maeda T; Kishino D; Nogami N; Tabata M; Harita S; Okada T; Kubo T; Hosokawa S; Fujiwara K; Gemba K; Yasugi M; Kozuki T; Kato Y; Katsui K; Kanazawa S; Ueoka H; Tanimoto M; Kiura K
    Eur J Cancer; 2014 Nov; 50(16):2783-90. PubMed ID: 25172295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label, multicenter, three-stage, phase II study of s-1 in combination with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer.
    Sandler A; Graham C; Baggstrom M; Herbst R; Zergebel C; Saito K; Jones D
    J Thorac Oncol; 2011 Aug; 6(8):1400-6. PubMed ID: 21673602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
    Harada H; Nishio M; Murakami H; Ohyanagi F; Kozuka T; Ishikura S; Naito T; Kaira K; Takahashi T; Horiike A; Nishimura T; Yamamoto N
    Clin Lung Cancer; 2013 Jul; 14(4):440-5. PubMed ID: 23540866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
    Wang J; Pang QS; Wang P; Wang J; Wang W
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):769-72. PubMed ID: 18396691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term clinical effect of conformal radiotherapy combined with tegafur gimeracil oteracil potassium in treating recurrent esophagus cancer.
    Jiao Y; Shen Y; Yan H; Liu Y; Tan H; Li J
    Pak J Med Sci; 2016; 32(5):1141-1145. PubMed ID: 27882010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium in metastatic and recurrent breast cancer.
    Otsuka H; Fujii T; Toh U; Iwakuma N; Takahashi R; Mishima M; Takenaka M; Kakuma T; Tanaka M; Shirouzu K
    Breast Cancer; 2015 Jul; 22(4):335-42. PubMed ID: 23827973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706).
    Ichinose Y; Seto T; Sasaki T; Yamanaka T; Okamoto I; Takeda K; Tanaka M; Katakami N; Sawa T; Kudoh S; Saka H; Nishimura Y; Nakagawa K; Fukuoka M
    J Thorac Oncol; 2011 Dec; 6(12):2069-75. PubMed ID: 22052226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma.
    Nonoshita T; Shioyama Y; Nakamura K; Nakashima T; Ohga S; Yoshitake T; Ohnishi K; Terashima K; Asai K; Honda H
    J Radiat Res; 2010; 51(4):481-4. PubMed ID: 20601829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
    Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
    Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer.
    Takigawa N; Kiura K; Hotta K; Hosokawa S; Nogami N; Aoe K; Gemba K; Fujiwara K; Harita S; Takemoto M; Himei K; Shinkai T; Fujiwara Y; Takata S; Tabata M; Kanazawa S; Tanimoto M;
    Lung Cancer; 2011 Jan; 71(1):60-4. PubMed ID: 20451285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma.
    Nomura T; Murakami R; Toya R; Teshima K; Nakahara A; Hirai T; Hiraki A; Nakayama H; Yoshitake Y; Ota K; Obayashi T; Yamashita Y; Oya N; Shinohara M
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1347-52. PubMed ID: 19628343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
    Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
    PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.
    Kim YS; Yoon SM; Choi EK; Yi BY; Kim JH; Ahn SD; Lee SW; Shin SS; Lee JS; Suh C; Kim SW; Kim DS; Kim WS; Park HJ; Park CI
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):76-81. PubMed ID: 15850905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404.
    Nishiyama O; Taniguchi H; Kondoh Y; Takada K; Baba K; Saito H; Sugino Y; Yamamoto M; Ogasawara T; Kondo M; Imaizumi K; Hasegawa Y; Suzuki R; Shimokata K;
    Anticancer Drugs; 2011 Sep; 22(8):811-6. PubMed ID: 21317767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.